Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.

Susan A Galel; D Michael Strong; Gary E Tegtmeier; Paul V Holland; Isamu K Kuramoto; Markus J. Kemper; Larry Pietrelli; James Gallarda

Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.

Standard

Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays. / Galel, Susan A; Strong, D Michael; Tegtmeier, Gary E; Holland, Paul V; Kuramoto, Isamu K; Kemper, Markus J.; Pietrelli, Larry; Gallarda, James.

in: TRANSFUSION, Jahrgang 42, Nr. 11, 11, 2002, S. 1507-1513.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Galel, SA, Strong, DM, Tegtmeier, GE, Holland, PV, Kuramoto, IK, Kemper, MJ, Pietrelli, L & Gallarda, J 2002, 'Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.', TRANSFUSION, Jg. 42, Nr. 11, 11, S. 1507-1513. <http://www.ncbi.nlm.nih.gov/pubmed/12421226?dopt=Citation>

APA

Galel, S. A., Strong, D. M., Tegtmeier, G. E., Holland, P. V., Kuramoto, I. K., Kemper, M. J., Pietrelli, L., & Gallarda, J. (2002). Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays. TRANSFUSION, 42(11), 1507-1513. [11]. http://www.ncbi.nlm.nih.gov/pubmed/12421226?dopt=Citation

Vancouver

Galel SA, Strong DM, Tegtmeier GE, Holland PV, Kuramoto IK, Kemper MJ et al. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays. TRANSFUSION. 2002;42(11):1507-1513. 11.

Bibtex

@article{50ef1383bed149ea87e033ff31ea709e,

title = "Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.",

abstract = "Two HCV antibody tests (EIA 2.0 [EIA2], Abbott; and the Version 3.0 ELISA [EIA3], Ortho) are currently licensed for screening of US blood donors. Testing of donors for HCV RNA allows comparison of the sensitivities of the two antibody-screening assays.",

keywords = "Adult, Humans, Male, Female, Reproducibility of Results, Sensitivity and Specificity, Predictive Value of Tests, Follow-Up Studies, Time Factors, Genotype, Immunoblotting, Biological Markers, United States/epidemiology, Mass Screening/*methods, Alanine Transaminase/blood, *Blood Donors, *Enzyme-Linked Immunosorbent Assay, Hepacivirus/genetics/immunology/*isolation & purification, Hepatitis C/*blood/diagnosis/epidemiology/virology, Hepatitis C Antibodies/*blood, *Immunoenzyme Techniques, RNA, Viral/*blood, Seroepidemiologic Studies, Viremia/*blood/diagnosis/epidemiology/virology, Adult, Humans, Male, Female, Reproducibility of Results, Sensitivity and Specificity, Predictive Value of Tests, Follow-Up Studies, Time Factors, Genotype, Immunoblotting, Biological Markers, United States/epidemiology, Mass Screening/*methods, Alanine Transaminase/blood, *Blood Donors, *Enzyme-Linked Immunosorbent Assay, Hepacivirus/genetics/immunology/*isolation & purification, Hepatitis C/*blood/diagnosis/epidemiology/virology, Hepatitis C Antibodies/*blood, *Immunoenzyme Techniques, RNA, Viral/*blood, Seroepidemiologic Studies, Viremia/*blood/diagnosis/epidemiology/virology",

author = "Galel, {Susan A} and Strong, {D Michael} and Tegtmeier, {Gary E} and Holland, {Paul V} and Kuramoto, {Isamu K} and Kemper, {Markus J.} and Larry Pietrelli and James Gallarda",

year = "2002",

language = "English",

volume = "42",

pages = "1507--1513",

journal = "TRANSFUSION",

issn = "0041-1132",

publisher = "Wiley-Blackwell",

number = "11",

}

RIS

TY - JOUR

T1 - Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.

AU - Galel, Susan A

AU - Strong, D Michael

AU - Tegtmeier, Gary E

AU - Holland, Paul V

AU - Kuramoto, Isamu K

AU - Kemper, Markus J.

AU - Pietrelli, Larry

AU - Gallarda, James

PY - 2002

Y1 - 2002

N2 - Two HCV antibody tests (EIA 2.0 [EIA2], Abbott; and the Version 3.0 ELISA [EIA3], Ortho) are currently licensed for screening of US blood donors. Testing of donors for HCV RNA allows comparison of the sensitivities of the two antibody-screening assays.

AB - Two HCV antibody tests (EIA 2.0 [EIA2], Abbott; and the Version 3.0 ELISA [EIA3], Ortho) are currently licensed for screening of US blood donors. Testing of donors for HCV RNA allows comparison of the sensitivities of the two antibody-screening assays.

KW - Adult

KW - Humans

KW - Male

KW - Female

KW - Reproducibility of Results

KW - Sensitivity and Specificity

KW - Predictive Value of Tests

KW - Follow-Up Studies

KW - Time Factors

KW - Genotype

KW - Immunoblotting

KW - Biological Markers

KW - United States/epidemiology

KW - Mass Screening/methods

KW - Alanine Transaminase/blood

KW - Blood Donors

KW - Enzyme-Linked Immunosorbent Assay

KW - Hepacivirus/genetics/immunology/isolation & purification

KW - Hepatitis C/blood/diagnosis/epidemiology/virology

KW - Hepatitis C Antibodies/blood

KW - Immunoenzyme Techniques

KW - RNA, Viral/blood

KW - Seroepidemiologic Studies

KW - Viremia/blood/diagnosis/epidemiology/virology